Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene

Blood

Volumn 90, Issue 1, 1997, Pages 204-208

  Fay, William P ^b   Parker, Andrew C ^b   Condrey, Lorraine R ^b   Shapiro, Amy D ^a  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENOTYPE; HUMAN; MALE; MUTATION; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030997665     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.204     Document Type: Article

References (30)

1. Loskutoff DJ, Sawdey M, Mimuro J: Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 9:87, 1989
2. Van Meijer M, Pannekoek H: Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: An update. Fibrinolysis 9:263, 1995
3. Potempa J, Korzus E, Travis J: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269:15957, 1994
4. Schleef RR, Loskutoff DJ: Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis 18:328, 1988
5. Reilly CF, McFall RC: Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cell. J Biol Chem 266:9419, 1991
6. Reilly CF, Fujita T, Mayer EJ, Siegfried ME: Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat. Arterioscler Thromb 11:1276, 1991
7. Fay WP, Murphy JG, Owen WG: High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Arterioscler Thromb Vasc Biol 16:1277, 1996
8. Hagege J, Peraldi MN, Rondeau E, Adida C, Delarue F, Medcalf R, Schleuning WD, Sraer JD: Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells. Am J Pathol 141:117, 1992
9. Podor TJ, Loskutoff DJ: Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor in the extracellular matrix of transforming growth factor-beta-activated endothelial cells. Ann NY Acad Sci 667:46, 1992
10. Seiffert D, Mimuro J, Schleef RR, Loskutoff DJ: Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Differ Dev 32:287, 1990
11. Ehrlich HJ, Gebbink RK, Keijer J, Linders M, Preissner KT, Pannekoek H: Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. J Biol Chem 265:13029, 1990
12. Ehrlich HJ, Gebbink RK, Preissner KT, Keijer J, Esmon NL, Mertens K, Pannekoek H: Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix. J Cell Biol 115:1773, 1991
13. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Nuffelen A, Prendergrast G, Cole M, Bronson R, Collen D, Mulligan R: Plasminogen activator inhibitor-1 gene deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 92:2746, 1993
14. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D: Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92:2756, 1993
15. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232, 1996
16. Hamsten A, Wiman B, de Faire U, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557, 1985
17. Hamsten A, de Faire U, Walldius G, Dahlen G, Szaraosi A, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 2:3, 1987
18. Frisco D, Chiarantini E, Boddi M, Rostagno C, Colella A, Gensini GF: Predictive value tor thrombotic disease of plasminogen activator inhibitor-1 plasma levels. Int J Clin Lab Res 23:78, 1993
19. Schleef RR, Higgins DL, Pillemer E, Levitt LJ: Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 83:1747, 1989
20. Dieval J, Nguyen G, Gross S, Delobel J, Kruithof EK: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 77:528, 1991
21. Lee MH, Vosburgh E, Anderson K, McDonagh J: Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood 81:2357, 1993
22. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D: Brief report: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 327:1729, 1992
23. Sherman PM, Lawrence DA, Yang AY, Vandenberg ET, Paielli D, Olson ST, Shore JD, Ginsburg D: Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J Biol Chem 267:7588, 1992
24. Keijer J, Ehrlich HJ, Linders M, Preissner KT, Pannekoek H: Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator. J Biol Chem 266:10700, 1991
25. Preissner KT, Jenne D: Structure of vitronectin and its biological role in haemostasis. Thromb Haemost 66:123, 1991
26. Ploplis V, Carmeliet P, Vazirzadeh S, Vlaenderen IV, Moons L, Plow E, Collen D: Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92:2585, 1995
27. Lijnen HR, Moons L, Beelen V, Carmeliet P, Collen D: Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice. Thromb Haemost 74:1126, 1995
28. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419, 1994
29. Bugge TH, Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794, 1995
30. Carmeliet P, Collen D: Evaluation of the plasminogen/plasmin system in transgenic mice. Fibrinolysis 8:269, 1994